GARFIELD-AF: A WORLDWIDE PROSPECTIVE REGISTRY OF PATIENTS WITH ATRIAL FIBRILLATION AT RISK OF STROKE Article Bassand J.P., Kayani G., Pieper K.S., Kakkar A.K., Apenteng P.N., Fitzmaurice D.A., Atar D., Camm A.J., Cools F., Corbalan R., Fox K.A.A., Goto S., Haas S., Hacke W., Jerjes-Sanchez C., Koretsune Y., Heuzey J.Y.L., Sawhney J.P.S., Oh S., Stepinska J., Cate V.T., Verheugt F.W.A., Garfield-Af Investigators F.T. Future Cardiology. Vol. 17. 2021. P. 19-38
CHANGES IN ANTICOAGULANT PRESCRIPTION IN DUTCH PATIENTS WITH RECENT-ONSET ATRIAL FIBRILLATION: OBSERVATIONS FROM THE GARFIELD-AF REGISTRY Article Seelig J., Hemels M.E.W., Verheugt F.W.A., Illingworth L., Pieper K., Lucassen A., Adriaansen H., Bongaerts M.C.M., Pieterse M., Herrman J.P.R., Hoogslag P., Hermans W., Groenemeijer B.E., Boersma L.V.A., Ten Cate H. Thrombosis Journal. BioMed Central. Vol. 18. 2020. 5 p.
ANTITHROMBOTICS: FROM ASPIRIN TO DOACS IN CORONARY ARTERY DISEASE AND ATRIAL FIBRILLATION (PART 3/5) Article Verheugt F.W.A., Ten Berg J.M., Storey R.F., Cuisset T., Granger C.B. Journal of the American College of Cardiology. Elsevier Science Publishing Company, Inc.. Vol. 74. 2019. P. 699-711